Sensory form of Guillain-Barré syndrome

Lancet

Volumn 357, Issue 9267, 2001, Pages 1465-

  Richard, A ^a   Hughes, C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; EPITOPE; GANGLIOSIDE; STEROID;

AUTOIMMUNE DISEASE; CLINICAL FEATURE; DEMYELINATION; DIFFERENTIAL DIAGNOSIS; DISABILITY; DISEASE SEVERITY; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE RESPONSE; MYELIN SHEATH; NERVE FIBER; NERVE FIBER DEGENERATION; NERVE POTENTIAL; NOTE; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; SCHWANN CELL; SENSORY NEUROPATHY;

EID: 0035849315     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(00)04672-9     Document Type: Note

References (7)

1. Hughes R.A.C., Gregson N.A., Hadden R.D.M., Smith K.J. Pathogenesis of Guillain-Barré syndrome. J Neuroimmunol. 100:1999;74-97.
2. Fisher M. Syndrome of ophthalmoplegia, ataxia and areflexia. N Engl J Med. 255:1956;57-65.
3. Oh S.J., LaGanke C., Claussen G.C. Sensory Guillain-Barré syndrome. Neurology. 56:2001;82-86.
4. Wilmshurst J.M., Macleod M.J., Hughes E., Hughes R.A.C. Acute sensory neuropathy in an adolescent girl following BCG vaccination. Eur J Paediatr Neurol. 3:1999;277-279.
5. Windebank A.J., Blexrud M.D., Dyck P.J., Daube J.R., Karnes J.L. The syndrome of acute sensory neuropathy: clinical features and electrophysiologic and pathologic changes. Neurology. 40:1990;584-591.
6. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 745:1997;32-36.
7. Ho T.W., Willison H.J., Nachamkin I., et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol. 45:1999;168-173.